Resting Heart Rate: Which Tests to Order Alongside

What Resting Heart Rate Actually Tells You

Resting heart rate reflects the balance between sympathetic and parasympathetic nervous system tone at baseline. A single number recorded during a clinic visit or from a wearable device captures how hard the heart works when the body has no external demand. That number changes with fitness, stress, medications, hydration, thyroid status, and dozens of other variables.

The American Heart Association defines a normal adult RHR as 60 to 100 bpm, but population data suggests the story is more nuanced. In the Copenhagen Heart Study, researchers tracked 2,798 men without known heart disease for 16 years and found that an RHR above 80 bpm at baseline was associated with a 45% increase in all-cause mortality compared to an RHR between 50 and 65 bpm [1]. That risk remained significant even after adjusting for blood pressure, cholesterol, smoking, and BMI. A separate analysis published in the Canadian Medical Association Journal (N=112,680) confirmed that each 10 bpm increase in RHR above 60 correlated with an 8 to 12% rise in cardiovascular mortality risk [2].

These associations do not prove causation. But they do explain why a persistently elevated or suppressed RHR should prompt further investigation, not just a note in the chart.

The Core Panel: Five Tests Every Clinician Should Pair with RHR

When resting heart rate falls outside the expected range, or when a patient reports palpitations, fatigue, or exercise intolerance, five laboratory tests form the minimum paired workup. Each test targets a different physiological driver of heart rate.

TSH with reflex free T4. Hyperthyroidism is one of the most common correctable causes of tachycardia. The American Thyroid Association recommends TSH as the first-line screening test, with free T4 and free T3 added when TSH is suppressed below 0.4 mIU/L [3]. In overt hyperthyroidism, resting heart rate frequently exceeds 90 bpm and can climb above 120 bpm with atrial fibrillation. Hypothyroidism, conversely, slows the heart. A TSH above 10 mIU/L paired with bradycardia in the 45 to 55 bpm range warrants thyroid hormone replacement evaluation per Endocrine Society guidelines [3].

Complete blood count (CBC). Anemia forces the heart to pump faster to maintain oxygen delivery. The World Health Organization defines anemia as hemoglobin <13 g/dL in men and <12 g/dL in women [4]. Even mild anemia (hemoglobin 10 to 12 g/dL) can raise RHR by 5 to 15 bpm, particularly during periods of dehydration or illness. The CBC also flags infection or inflammatory states that independently raise heart rate.

Basic metabolic panel (BMP). Electrolyte imbalances, specifically in potassium, calcium, and magnesium, directly affect cardiac conduction. Hypokalemia (K+ <3.5 mEq/L) and hyperkalemia (K+ >5.0 mEq/L) both cause arrhythmias that manifest as irregular or elevated RHR [5]. The BMP simultaneously screens kidney function through creatinine and eGFR, relevant because chronic kidney disease raises cardiovascular risk and commonly coexists with autonomic dysfunction.

Fasting glucose or HbA1c. The American Diabetes Association classifies prediabetes as a fasting glucose of 100 to 125 mg/dL or HbA1c of 5.7% to 6.4% [6]. Insulin resistance and type 2 diabetes both increase sympathetic nervous system activity, and resting tachycardia is an early marker of cardiac autonomic neuropathy. The ARIC study (N=15,792) found that individuals with diabetes and an RHR above 80 bpm had double the risk of heart failure hospitalization versus those with diabetes and an RHR below 70 bpm [7].

Lipid panel. An RHR evaluation without cardiovascular risk context is incomplete. The 2018 ACC/AHA cholesterol guidelines recommend a fasting lipid panel for all adults aged 20 and older as part of cardiovascular risk assessment [8]. Combining RHR data with LDL-C, triglycerides, and HDL-C allows a more accurate 10-year ASCVD risk calculation.

Second-Tier Labs: When the Basics Are Not Enough

If the five core tests return normal and the RHR abnormality persists, a second round of testing addresses less common but clinically significant causes.

Ferritin and serum iron with TIBC. A normal hemoglobin does not exclude iron deficiency. Ferritin can drop below 30 ng/mL (indicating depleted iron stores) well before hemoglobin falls below threshold. Iron-deficient states without frank anemia still increase heart rate and reduce exercise capacity, as demonstrated in a Lancet meta-analysis of iron supplementation in non-anemic, iron-deficient heart failure patients (N=839) [9]. The study found that IV iron improved 6-minute walk distance and reduced hospitalization risk even when hemoglobin was normal.

Serum magnesium. Standard metabolic panels do not include magnesium. Yet hypomagnesemia (Mg <1.7 mg/dL) causes or worsens tachyarrhythmias, including premature ventricular contractions and atrial fibrillation. The National Institutes of Health estimates that 48% of Americans consume less than the estimated average requirement for magnesium [10]. Ordering serum magnesium alongside a BMP costs minimal additional expense and catches a frequently overlooked contributor to elevated RHR.

BNP or NT-proBNP. B-type natriuretic peptide rises when the heart is under volume or pressure overload. An RHR above 90 bpm combined with BNP above 100 pg/mL (or NT-proBNP above 300 pg/mL) raises suspicion for heart failure, even in patients without overt edema or dyspnea [11]. The ACC/AHA heart failure guidelines recommend BNP measurement in any patient presenting with symptoms suggestive of heart failure [11].

Morning cortisol or 24-hour urinary free cortisol. Persistent tachycardia with weight gain, hypertension, and glucose intolerance may signal hypercortisolism. The Endocrine Society's 2008 clinical practice guideline recommends screening with at least two first-line tests: late-night salivary cortisol, 24-hour urinary free cortisol, or 1 mg overnight dexamethasone suppression test [12].

Plasma or 24-hour urine catecholamines and metanephrines. This panel is reserved for episodic tachycardia accompanied by paroxysmal hypertension, headache, and diaphoresis. Pheochromocytoma is rare (2 to 8 per million per year), but the Endocrine Society guideline recommends biochemical testing in any patient with a classic triad of symptoms [13].

Understanding Normal Resting Heart Rate Range

The 60-to-100 bpm range taught in medical school is a population average. Real-world "normal" depends on age, fitness, medication use, and time of day.

Trained endurance athletes commonly have an RHR of 40 to 55 bpm due to increased stroke volume and vagal tone. This is physiologic bradycardia and requires no treatment if the person is asymptomatic. A 2018 study in Heart (BMJ) examined 3,320 elite athletes and found that 8.4% had an RHR below 40 bpm on resting ECG, none of whom required pacing over a 5-year follow-up [14].

Age also matters. A meta-analysis in PLOS ONE covering 92 studies and 170,000 participants found that mean RHR increases slightly from the third to the seventh decade, with women averaging 3 to 5 bpm higher than men across all age groups [15]. Among adults over 65, an RHR above 80 bpm carries a stronger mortality signal than in younger populations, according to data from the Cardiovascular Health Study (N=5,888) published in the American Journal of Cardiology [16].

Wearable devices measure heart rate during sleep, which is typically 8 to 15 bpm lower than seated daytime measurements. Comparing wearable data to clinic readings without accounting for this difference leads to confusion. The CDC notes that measurement context matters as much as the number itself [17].

How Medications Shift Resting Heart Rate

Before attributing an abnormal RHR to an underlying disease, review the medication list. This step alone resolves many otherwise puzzling readings.

Beta-blockers (metoprolol, atenolol, propranolol) lower RHR by 10 to 20 bpm at therapeutic doses. Non-dihydropyridine calcium channel blockers (diltiazem, verapamil) produce a similar effect. Ivabradine, approved specifically for heart rate reduction, lowers RHR by a mean of 10 bpm without affecting blood pressure, as demonstrated in the SHIFT trial (N=6,558) [18].

On the other side, stimulant medications (amphetamine salts, methylphenidate), decongestants (pseudoephedrine), and thyroid hormone replacement at supratherapeutic doses all raise RHR. Albuterol and other beta-2 agonists used for asthma can increase heart rate by 5 to 15 bpm. Even caffeine, at doses above 400 mg per day, has been shown to raise resting heart rate by 2 to 5 bpm in caffeine-naive individuals, per a review in the Journal of the American Heart Association [19].

Document every prescription, over-the-counter product, and supplement before deciding whether a lab workup is necessary. A patient on 100 mg of metoprolol with an RHR of 52 bpm does not need a bradycardia evaluation.

How to Lower Resting Heart Rate

For patients whose labs reveal no correctable cause and whose RHR remains persistently above 75 to 80 bpm, lifestyle interventions are the first-line approach.

Aerobic exercise is the most effective non-pharmacologic method. A Cochrane systematic review of 21 randomized controlled trials (N=1,110) found that regular aerobic training reduced RHR by an average of 6 bpm over 12 to 24 weeks [20]. The greatest reductions occurred in sedentary individuals who began moderate-intensity exercise (brisk walking, cycling at 50 to 70% of maximal heart rate) for 150 minutes per week, consistent with the AHA physical activity guidelines.

Stress reduction through structured programs also lowers RHR. A randomized trial published in Psychosomatic Medicine (N=201) found that an 8-week mindfulness-based stress reduction program decreased RHR by 2.3 bpm compared to waitlist controls [21]. The effect was modest but additive on top of exercise.

Sleep duration matters. Data from the UK Biobank (N=91,394) published in the European Heart Journal showed that adults sleeping fewer than 6 hours per night had an RHR approximately 3 bpm higher than those sleeping 7 to 8 hours, after adjustment for physical activity and BMI [22].

Alcohol reduction has a measurable impact. A randomized crossover trial in PLOS Medicine (N=51) demonstrated that complete alcohol abstinence for 4 weeks lowered RHR by 2.4 bpm in moderate drinkers [23].

When Low Resting Heart Rate Needs Investigation

An RHR below 60 bpm in a non-athlete who is not taking rate-lowering medication warrants a targeted workup. The priority is distinguishing physiologic bradycardia from pathologic causes.

The paired lab approach for bradycardia investigation starts with TSH (hypothyroidism), a BMP (hyperkalemia), and a CBC. If those are unrevealing, consider Lyme serology in endemic regions (Lyme carditis causes AV block and bradycardia) and a sleep study referral if the patient reports excessive daytime sleepiness (obstructive sleep apnea paradoxically raises nocturnal heart rate but can cause relative daytime bradycardia through vagal rebound).

An ECG is essential alongside labs. Sinus bradycardia with a normal PR interval and no pauses below 3 seconds is almost always benign. First-degree or second-degree AV block, particularly Mobitz type II, requires cardiology referral regardless of lab findings [24].

The USPSTF does not currently recommend universal screening ECGs in asymptomatic adults, but the AHA recognizes that RHR below 50 bpm with syncope or presyncope constitutes a class I indication for further cardiac evaluation [24].

Building the Order Set: A Practical Approach

Not every patient needs every test. Match the order set to the clinical picture.

Tachycardia workup (RHR consistently >90 bpm): TSH with reflex free T4, CBC, BMP, fasting glucose or HbA1c, lipid panel. Add ferritin and magnesium if initial results are normal. Add BNP if dyspnea, edema, or exercise intolerance is present.

Bradycardia workup (RHR consistently <50 bpm in a non-athlete): TSH, BMP (potassium focus), CBC. ECG. Consider Lyme antibody if geographically appropriate.

Routine cardiovascular optimization (RHR 70 to 85 bpm, no symptoms): Lipid panel, fasting glucose or HbA1c, TSH. Repeat RHR measurement over three mornings with a standardized protocol: seated, after 5 minutes of rest, bladder emptied, no caffeine for 2 hours.

Post-medication-change check: Repeat RHR 2 to 4 weeks after starting or adjusting beta-blockers, calcium channel blockers, ivabradine, or thyroid hormone. Pair with BMP to catch electrolyte shifts, especially potassium.

The total cost of the core five-test panel (TSH, CBC, BMP, glucose, lipid panel) ranges from $45 to $150 at direct-pay lab pricing through Quest or Labcorp. Insurance typically covers these tests when ordered with an appropriate ICD-10 code (R00.0 for tachycardia, R00.1 for bradycardia, or Z13.6 for cardiovascular screening).